Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics

Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics

Colorectal cancer (CRC) represents the third most common cancer in males and second in females worldwide. Here, we performed a quantitative 8-plex iTRAQ proteomics analysis of the secreted proteins from five colonic fibroblast cultures and three colon cancer epithelial cell lines. We identified 1114...

Full description

Bibliographic Details
Main Authors: Qiao, Jie, Fang, Cai-Yun, Chen, Sun-Xia, Wang, Xiao-Qing, Cui, Shu-Jian, Liu, Xiao-Hui, Jiang, Ying-Hua, Wang, Jie, Zhang, Yang, Yang, Peng-Yuan, Liu, Feng
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745773/

Similar Items

Similar Items